FDA Sets Outcomes Benchmarks For Actual Use Trials
This article was originally published in The Tan Sheet
Executive Summary
FDA is providing OTC switch application sponsors with pre-defined benchmarks for actual use trials, Center for Drug Evaluation and Research executive Andrea Leonard-Segal says
You may also be interested in...
FDA Panel To Influenza Home MedKit Sponsors: Get Real
Roche begins label comprehension studies this month to support development of aTamiflu home MedKit for the treatment or prophylaxis of pandemic influenza virus, under an initiative driven by the Department of Health and Human Services
FDA Panel To Influenza Home MedKit Sponsors: Get Real
Roche begins label comprehension studies this month to support development of aTamiflu home MedKit for the treatment or prophylaxis of pandemic influenza virus, under an initiative driven by the Department of Health and Human Services
FDA Panel To Influenza Home MedKit Sponsors: Get Real
Roche begins label comprehension studies this month to support development of aTamiflu home MedKit for the treatment or prophylaxis of pandemic influenza virus, under an initiative driven by the Department of Health and Human Services